COMP <GO>
FSTR vs TMO // RETURN ON INVESTED CAPITAL (ROIC)
L.B. Foster Company (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: FSTR 3
— TMO 7
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: FSTR
LAST: $36.39 (+0.47%) • MKT CAP: $382.8M
roic
10.10%
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
roic
9.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FSTR VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | FSTR | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 21.10% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 10.10% | 9.30% | +0.80 | FSTR | /roic <GO> |
| EV/EBITDA & P/E Valuation | 12.3x | 30.4x | -18.10 | FSTR | /valuation <GO> |
| Free Cash Flow Yield | 6.58% | 2.40% | +4.18 | FSTR | /fcf-yield <GO> |
| Operating Margin | 4.10% | 17.40% | -13.30 | TMO | /operating-margins <GO> |
| Net Profit Margin | 1.40% | 15.10% | -13.70 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | — | 3.90% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 4.50 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 8/9 | -3.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.6 | 62.9 | -14.27 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 47.2x | 36.3x | +10.90 | TMO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $382.8M | $262.22B | -$261.83B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | FSTR REV | TMO REV | FSTR GROSS % | TMO GROSS % | FSTR FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $540.0M | $44.56B | 21.1% | — | $25.2M | $6.29B |
| FY 2024 | $530.8M | $42.88B | 22.2% | — | $12.8M | $7.27B |
| FY 2023 | $0 | $42.86B | — | — | $37.0M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FSTR // BETA —
TMO // BETA 0.94